1. Home
  2. ATHE vs NIVF Comparison

ATHE vs NIVF Comparison

Compare ATHE & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • NIVF
  • Stock Information
  • Founded
  • ATHE 1997
  • NIVF 2011
  • Country
  • ATHE Australia
  • NIVF Thailand
  • Employees
  • ATHE N/A
  • NIVF N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • NIVF
  • Sector
  • ATHE Health Care
  • NIVF
  • Exchange
  • ATHE Nasdaq
  • NIVF NYSE
  • Market Cap
  • ATHE 10.1M
  • NIVF 9.2M
  • IPO Year
  • ATHE N/A
  • NIVF N/A
  • Fundamental
  • Price
  • ATHE $1.07
  • NIVF $0.51
  • Analyst Decision
  • ATHE Buy
  • NIVF
  • Analyst Count
  • ATHE 1
  • NIVF 0
  • Target Price
  • ATHE $4.00
  • NIVF N/A
  • AVG Volume (30 Days)
  • ATHE 13.7K
  • NIVF 2.5M
  • Earning Date
  • ATHE 12-03-2024
  • NIVF 12-03-2024
  • Dividend Yield
  • ATHE N/A
  • NIVF N/A
  • EPS Growth
  • ATHE N/A
  • NIVF N/A
  • EPS
  • ATHE N/A
  • NIVF 0.21
  • Revenue
  • ATHE $2,681,669.00
  • NIVF $5,136,153.00
  • Revenue This Year
  • ATHE N/A
  • NIVF N/A
  • Revenue Next Year
  • ATHE N/A
  • NIVF N/A
  • P/E Ratio
  • ATHE N/A
  • NIVF $2.57
  • Revenue Growth
  • ATHE 2.63
  • NIVF N/A
  • 52 Week Low
  • ATHE $1.00
  • NIVF $0.47
  • 52 Week High
  • ATHE $5.41
  • NIVF $17.24
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 37.45
  • NIVF 36.82
  • Support Level
  • ATHE $1.05
  • NIVF $0.47
  • Resistance Level
  • ATHE $1.13
  • NIVF $0.67
  • Average True Range (ATR)
  • ATHE 0.07
  • NIVF 0.11
  • MACD
  • ATHE -0.01
  • NIVF -0.02
  • Stochastic Oscillator
  • ATHE 23.88
  • NIVF 8.94

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About NIVF NEWGENIVF GROUP LIMITED

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Share on Social Networks: